The legacy of Viagra and its parent , copyright, presents a fascinating picture for potential investors. While the iconic drug initially fueled enormous profits , its patent has lapsed , leading to generic versions flooding the market . This reduction in cost presents a real hurdle for copyright and any fund considering a significant position in th